<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Neuropsychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Neuropsychiatry</journal-id>
<journal-id journal-id-type="publisher-id">MNP</journal-id>
<journal-title-group>
<journal-title>Molecular Neuropsychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">2296-9209</issn>
<issn pub-type="epub">2296-9179</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27867940</article-id>
<article-id pub-id-type="pmc">5109985</article-id>
<article-id pub-id-type="doi">10.1159/000448173</article-id>
<article-id pub-id-type="publisher-id">mnp-0002-0151</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxytocin Receptor <italic>(OXTR)</italic> Methylation and Cognition in Psychotic Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Grove</surname>
<given-names>Tyler B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burghardt</surname>
<given-names>Kyle J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kraal</surname>
<given-names>A. Zarina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dougherty</surname>
<given-names>Ryan J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>Stephan F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ellingrod</surname>
<given-names>Vicki L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>a</sup>Department of Psychology, University of Michigan, Ann Arbor, Mich., USA</aff>
<aff id="aff2"><sup>b</sup>Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Mich., USA</aff>
<aff id="aff3"><sup>c</sup>Department of Psychiatry, University of Michigan, Ann Arbor, Mich., USA</aff>
<aff id="aff4"><sup>d</sup>Luskin School of Public Affairs, University of California, Los Angeles, Los Angeles, Calif.,USA</aff>
<aff id="aff5"><sup>e</sup>College of Pharmacy, University of Michigan, Ann Arbor, Mich., USA</aff>
<author-notes>
<corresp id="cor1">*Tyler B. Grove, Department of Psychology, University of Michigan, Ann Arbor, MI 48109 (USA), E-Mail <email>tylerg@umich.edu</email></corresp>
<fn fn-type="other">
<p>The first two authors are listed as primary.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>10</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>2</volume>
<issue>3</issue>
<fpage>151</fpage>
<lpage>160</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>2</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>6</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Previous reports have identified an association between cognitive impairment and genetic variation in psychotic disorders. In particular, this association may be related to abnormal regulation of genes responsible for broad cognitive functions such as the oxytocin receptor <italic>(OXTR)</italic>. Within psychotic disorders, it is unknown if <italic>OXTR</italic> methylation, which can have important implications for gene regulation, is related to cognitive function. The current study examined peripheral blood <italic>OXTR</italic> methylation and general cognition in people with schizophrenia, schizoaffective disorder, and psychotic disorder not otherwise specified (N = 101). Using hierarchical multiple regression analysis, methylation at the Chr3:8767638 site was significantly associated with composite cognitive performance independent of demographic and medication factors while controlling for multiple testing in this combined diagnostic sample (adjusted p = 0.023).</p>
</abstract>
<kwd-group>
<title>Key Words</title>
<kwd>Psychosis</kwd>
<kwd>Cognition</kwd>
<kwd>Oxytocin receptor</kwd>
<kwd>Methylation</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="4"></table-count>
<ref-count count="84"></ref-count>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>